Singh Sid 4

4 · EQUIFAX INC · Filed Aug 24, 2021

Form 4

Period: 2021-08-20

President - USIS

Transactions

Exercise/Conversion
Common Stock
2021-08-20$110.76/sh+6,021$666,886→ 17,811 total
Sale
Common Stock
2021-08-20$256.19/sh−3,209$822,101→ 14,407 total
Sale
Common Stock
2021-08-20$257.19/sh−4,224$1,086,354→ 10,183 total
Exercise/Conversion
Stock Option/Right to Buy
2021-08-20−6,021→ 3,011 total
Exercise: $110.76Exp: 2029-02-22→ Common Stock (6,021 underlying)
Sale
Common Stock
2021-08-20$258.04/sh−195$50,317→ 17,616 total

Footnotes (6)

[F1]The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 5/24/2021.
[F2]Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
[F3]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $257.815 to $258.50, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F4]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $255.715 to $256.665, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F5]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $256.76 to $257.73, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
[F6]The option vests in three equal annual increments beginning 2/22/2020.

Documents

1 file